BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22711667)

  • 1. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
    Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S
    J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
    Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
    Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].
    Cui S; Li H; Tian B; Song C; Hu B
    Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):753-760. PubMed ID: 30309426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery.
    Nguyen NT; Hinojosa MW; Fayad C; Varela E; Konyalian V; Stamos MJ; Wilson SE
    Ann Surg; 2007 Dec; 246(6):1021-7. PubMed ID: 18043105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
    Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
    J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening strategy using sequential serum D-dimer assay for the detection and prevention of venous thromboembolism after elective brain tumor surgery.
    Aishima K; Yoshimoto Y
    Br J Neurosurg; 2013 Jun; 27(3):348-54. PubMed ID: 23131147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
    Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
    Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
    Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative venous thromboembolism predicts survival in cancer patients.
    Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y
    Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of venous thromboembolism occurrence in medical patients among the insured population.
    Spyropoulos AC; Hussein M; Lin J; Battleman D
    Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
    Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
    Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
    Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer before chemotherapy might predict venous thromboembolism.
    Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.
    Liem TK; Huynh TM; Moseley SE; Minjarez RC; Landry GJ; Mitchell EL; Deloughery TG; Moneta GL
    J Vasc Surg; 2010 Sep; 52(3):651-7. PubMed ID: 20558025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer.
    Connolly GC; Dalal M; Lin J; Khorana AA
    Lung Cancer; 2012 Dec; 78(3):253-8. PubMed ID: 23026639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.